Mouwasat Medical Services dividend and valuation
Valuation
Mouwasat Medical Services paid SAR 3.13 per share in dividends over the last 12 months (yield 5.5%). Last ex-dividend date: October 18, 2026. The P/E ratio is 13.5. The average price target of 13 analysts is SAR 75.92.
Data as of November 22, 2026
Mouwasat Medical Services compared with similar companies
Mouwasat Medical Services's P/E (trailing 12 months): 13.5, −51% against the median of a group of 10 similar companies (27.7).
| Metric | Mouwasat Medical Services | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 13.5 | 27.7 | 12.6 – 39.6 | Middle |
| Forward P/E | 13.1 | 17.3 | 10.7 – 27.2 | Middle |
| EV/EBITDA | 10.9 | 13.2 | 9.79 – 26.3 | Middle |
| Price/book | 2.77 | 3.38 | 1.69 – 7.54 | Middle |
| Price/sales | 3.33 | 1.81 | 0.65 – 5.41 | Middle |
| Gross margin | 40.6% | 32.3% | 25.0% – 44.9% | Middle |
| Operating margin | 25.8% | 10.9% | 8.2% – 17.9% | High |
| Net margin | 24.3% | 7.0% | 3.9% – 12.8% | High |
| ROE | 21.2% | 15.8% | 9.1% – 20.4% | High |
| Debt/equity | 0.29 | 0.89 | 0.56 – 1.88 | Low |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Mouwasat Medical Services: valuation over time
On the latest fiscal year's earnings (2025), Mouwasat Medical Services's P/E today is 13.8, below the median of its last 10 fiscal years (26.2; between 16.2 and 34.9 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (5.5%) is above the median of the last 10 fiscal years (1.9%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | SAR 66.65 | SAR 4.11 | 16.2 | SAR 2.13 | 3.2% |
| 2024 | SAR 85.10 | SAR 3.23 | 26.4 | SAR 2.00 | 2.4% |
| 2023 | SAR 111.80 | SAR 3.29 | 34.0 | SAR 1.75 | 1.6% |
| 2022 | SAR 104.50 | SAR 3.00 | 34.9 | SAR 1.50 | 1.4% |
| 2021 | SAR 86.90 | SAR 2.89 | 30.1 | SAR 1.38 | 1.6% |
| 2020 | SAR 69.00 | SAR 2.64 | 26.1 | SAR 1.25 | 1.8% |
| 2019 | SAR 44.00 | SAR 2.11 | 20.9 | SAR 1.00 | 2.3% |
| 2018 | SAR 40.25 | SAR 1.80 | 22.3 | SAR 0.88 | 2.2% |
| 2017 | SAR 37.85 | SAR 1.68 | 22.5 | SAR 0.75 | 2.0% |
| 2016 | SAR 36.75 | SAR 1.29 | 28.6 | SAR 0.63 | 1.7% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- SAR 11.49B
- Enterprise value
- SAR 12.5B
- PEG
- 2.42
- EV/revenue
- 3.62
Profitability and growth
- ROA
- 8.8%
- ROIC
- 10.7%
- Revenue growth (year over year)
- 10.2%
- Earnings growth (year over year)
- -5.8%
Financial health
- Total cash
- SAR 393.71M
- Total debt
- SAR 1.26B
- Current ratio
- 1.72
- Quick ratio
- 1.35
- Altman Z-Score
- 4.91
- Piotroski F-Score
- 5.00
Dividends
- Annual dividend per share
- SAR 3.13
- Dividend yield
- 5.5%
- Payout ratio
- 73.5%
- Ex-dividend date
- October 18, 2026
Analysts and estimates
- Average price target
- SAR 75.92
- Median price target
- SAR 70.00
- High price target
- SAR 100.00
- Low price target
- SAR 57.00
- Analysts with a price target
- 13
- Consensus
- Buy
- Forward EPS
- SAR 4.39
- EPS estimate, current year
- SAR 4.22
Shares and trading
- Beta
- 0.11
- Average volume
- 357.8K
- Shares outstanding
- 200M
- Float
- 90.76M
- Institutional ownership
- 5.4%
- Insider ownership
- 51.9%
